Diffusion Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Diffusion Pharmaceuticals's estimated annual revenue is currently $7.5M per year.
- Diffusion Pharmaceuticals's estimated revenue per employee is $416,667
- Diffusion Pharmaceuticals's total funding is $119.5M.
Employee Data
- Diffusion Pharmaceuticals has 18 Employees.
- Diffusion Pharmaceuticals grew their employee count by -10% last year.
Diffusion Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Finance | Reveal Email/Phone |
2 | Director Project Management | Reveal Email/Phone |
3 | Senior Director Information Technologies | Reveal Email/Phone |
4 | Chief Scientific Officer | Company Co-founder | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Project Manager | Reveal Email/Phone |
7 | Senior Medical Advisor | Reveal Email/Phone |
Diffusion Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $15.9M | 79 | 25% | $210M | N/A |
#2 | $30.2M | 182 | N/A | N/A | N/A |
#3 | $6.6M | 33 | 6% | N/A | N/A |
#4 | $7.8M | 39 | -39% | N/A | N/A |
#5 | $4.8M | 24 | 4% | N/A | N/A |
#6 | $12.5M | 62 | 7% | N/A | N/A |
#7 | $22.1M | 110 | 7% | N/A | N/A |
#8 | $11.7M | 58 | -9% | N/A | N/A |
#9 | $5.8M | 29 | -12% | N/A | N/A |
#10 | $42.4M | 211 | N/A | N/A | N/A |
What Is Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals LLC is a drug discovery and development company commercializing a pipeline of proprietary compounds from the novel trans bipolar carotenoid family of molecules. Diffusion's lead compound, trans sodium crocetinate (designated as DP-00-01, and often referred to as TSC) is currently in the late pre-clinical stage of development to treat oxygen deficiency at the cellular level across a variety of life-threatening conditions. This oxygen deficiency, known by the medical term “hypoxia,” is implicated in hemorrhage, stroke, heart attack, congestive heart failure, respiratory disorders, certain cancerous tumors and other conditions.
keywords:Biotechnology
$119.5M
Total Funding
18
Number of Employees
$7.5M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Diffusion Pharmaceuticals News
Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance PlanSplit Expected to be Effective for Trading...
Diffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of Stockholders. Published: Apr 08, 2022. Special Meeting of...
CHARLOTTESVILLE, Va., April 08, 2022 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (Diffusion or the Company),...
Diffusion Pharmaceuticals LLC, a Charlottesville, Virginia-based biotechnology company developing innovative cancer treatments, closed a $5m financing. The round, which is an addition to the $5m financing announced in September, 2012 (read here), consists of convertible notes issued primarily t ...
Diffusion Pharmaceuticals LLC, a Charlottesville, VA-based biotechnology company developing innovative cancer treatments, has closed a $5m financing. The financing consists of convertible notes issued primarily to existing investors. The company intends to use the proceeds to fund the ongoing ...
Other Companies in Charlottesville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 18 | 20% | N/A |
#2 | $2.8M | 18 | -22% | N/A |
#3 | $2.8M | 18 | -14% | N/A |
#4 | $1.7M | 19 | -17% | N/A |
#5 | $1.7M | 19 | 6% | N/A |